why choose us

First received: February 07, 2023

Clinical Trial: Evaluation of SNDX-5613 in Participants With Colorectal Cancer and Other Solid Tumors

Study Status: Completed

Recruit Status: RECRUITING

Condition: Colorectal Cancer

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2 Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SNDX-5613 in Patients With Colorectal Cancer and Other Solid Tumors

Brief Summary: This study will evaluate the safety, tolerability, pharmacokinetics (PK), and anti-tumor activity of SNDX-5613 in participants with colorectal cancer (CRC) or other solid tumors who have failed at least 1 prior line of therapy.

Read more